TXG FINANCIAL STATEMENTS

10X Genomics Inc — balance sheet, income statement and cash flow trends

TXG10X Genomics Inc

🇺🇸 USA · NASDAQ · Healthcare · Health Information Services

Value it Duel

Income Statement

Quarterly progression — trailing-twelve-month values

RevenueNet Income

Profit Funnel

Q1 2026 · TTM

Percentages are relative to revenue.

Key Figures

YoY change

Revenue638.8 M $+2.3%

Gross Profit444.6 M $+4.1%

Operating Income-38.7 M $—

EBITDA93.3 M $—

Net Income-22.7 M $—

Peer Comparison· Health Information Services

Company	Rev. Growth	Gross Margin	EBITDA Margin	Net Margin
TXG	2.3%	69.6%	14.6%	-3.5%
PME	30.3%	78.4%	78.4%	97.6%
FONET	53.5%	39.8%	49.6%	26.0%
Industry median	7.1%	63.4%	12.4%	1.5%

Company	Rev. Growth	Gross Margin	EBITDA Margin	Net Margin
TXG	2.3%	69.6%	14.6%	-3.5%
WAY	18.6%	65.2%	35.8%	10.9%
DOCS	13.1%	89.1%	41.3%	30.4%
SLGC	-19.7%	41.2%	-166.7%	-159.5%
PRVA	24.7%	9.6%	2.5%	1.0%
HQY	7.6%	72.7%	34.3%	17.3%
Industry median	7.1%	63.4%	12.4%	1.5%

Balance Sheet

Quarterly period-end values

Total AssetsTotal LiabilitiesEquity

Capital Structure

Q1 2026

Equity814.3 M $80%
Current Liabilities113.6 M $11%
Long-term Liabilities87.8 M $9%

Key Figures

YoY change

Total Assets1 B $+12.4%

Total Liabilities201.4 M $+2.5%

Total Equity814.3 M $+15.2%

Cash & ST Investments539.8 M $+26.5%

Total Debt81.4 M $+1.6%

Net Debt-408.9 M $—

Peer Comparison· Health Information Services

Company	Current Ratio	Debt/Equity	NetDebt/EBITDA	Equity/Assets
TXG	5.90	10.0%	-4.91	80.2%
PME	6.22	1.1%	-1.16	72.8%
FONET	2.31	2.5%	-0.21	90.9%
Industry median	1.83	22.0%	-0.01	64.7%

Company	Current Ratio	Debt/Equity	NetDebt/EBITDA	Equity/Assets
TXG	5.90	10.0%	-4.91	80.2%
WAY	1.76	37.7%	3.21	67.4%
DOCS	6.09	1.1%	-2.78	84.6%
SLGC	17.79	0.6%	3.31	87.9%
PRVA	1.61	1.2%	-7.28	53.1%
HQY	3.44	48.1%	1.57	61.9%
Industry median	1.83	22.0%	-0.01	64.7%

Cash Flow Statement

Quarterly progression — trailing-twelve-month values

Operating Cash FlowCapital ExpendituresFree Cash Flow

Cash Flow Bridge

Q1 2026 · TTM

Key Figures

YoY change

Operating Cash Flow127.8 M $+125.3%

Capital Expenditures5.6 M $-54.4%

Free Cash Flow122.2 M $+175.4%

Dividends Paid——

Peer Comparison· Health Information Services

Company	CF Margin	FCF Margin	CapEx Ratio	CF/Net Income
TXG	20.0%	19.1%	0.9%	-564.2%
PME	56.5%	56.3%	0.2%	57.9%
FONET	45.0%	9.6%	32.1%	173.0%
Industry median	17.1%	13.0%	1.6%	165.1%

Company	CF Margin	FCF Margin	CapEx Ratio	CF/Net Income
TXG	20.0%	19.1%	0.9%	-564.2%
WAY	28.6%	25.4%	3.1%	262.0%
DOCS	50.6%	49.2%	1.4%	166.5%
SLGC	-153.4%	-149.2%	12.1%	96.2%
PRVA	6.1%	6.1%	0.1%	634.1%
HQY	36.6%	36.5%	2.5%	212.3%
Industry median	17.1%	13.0%	1.6%	165.1%

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on TXG

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 2, 26. This content is for informational purposes only and is not investment advice.